Acasta Enterprises Incorporated

Acasta Enterprises Announces Completion of Private Placement

Acasta Enterprises Inc. (TSX: AEF) (“Acasta” or the Corporation”) announced today that further to its press release dated June 7, 2019, it has completed a private placement (the “Subsequent Private Placement”) of 2,166,017 Class B Shares of the Corporation (the “Shares”) at a price of $0.68 per share for aggregate gross proceeds of $1,472,891 which is intended to be used to reduce the Corporation’s outstanding bank indebtedness. The private placement was effected at the market price.

The Corporation offered to certain of its larger shareholders (the “Offered Shareholders”) the opportunity to participate in the Subsequent Private Placement on the same terms as its initial private placement, which closed on June 7, 2019, on a pro rata basis. As announced in the June 7, 2019 press release, the offered unsubscribed for Shares (the “Unsubscribed for Shares”) were offered to third parties, as an Offered Shareholder did not accept all or a portion of the offer to subscribe. Corporations controlled by the co-CEO’s of the Corporation subscribed for the Unsubscribed for Shares, being an aggregate of 929,506 Shares.

Following the completion of the Subsequent Private Placement, the co-CEO’s of the Corporation will indirectly control an aggregate of 29,749,664 Class B Shares or approximately 40% of the outstanding Shares. The completion of the Subsequent Private Placement did not materially affect control of the Corporation and has received the conditional approval of the Toronto Stock Exchange.

The Subsequent Private Placement may be considered a “related party transaction” pursuant to Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The Subsequent Private Placement was approved by the independent directors of the Corporation and is exempt from the formal valuation and minority approval requirements, respectively, of MI 61-101 as neither the fair market value of the Subsequent Private Placement, nor the fair market value of the applicable Shares, exceeds 25% of the Corporation’s market capitalization (as calculated pursuant to MI 61-101).

Pursuant to applicable Canadian securities laws, all securities issued pursuant to the Subsequent Private Placement are subject to, among other things, a statutory hold period of four months and one day, which will expire on October 29, 2019. The Subsequent Private Placement remains subject to the final approval of the Toronto Stock Exchange.

Cautions Regarding Future Plans and Forward Looking Information

Certain statements contained in this press release constitute forward-looking statements within the meaning of applicable Canadian securities laws which reflect the Corporation’s current expectations and projections about future results. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “outlook”, “objective”, “may”, “will”, “expect”, “intent”, “estimate”, “anticipate”, “believe”, “consider”, “should”, “plans”, “predict”, “estimate”, “potential”, “could”, “likely”, “approximately”, “scheduled”, “forecast”, “variation” or “continue”, or similar expressions suggesting future outcomes or events. The forward-looking statements made in this press release relate only to events or information as of the date on which the statements are made in this press release. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this press release. Such forward-looking statements are based on a number of assumptions that may prove to be incorrect.

Except as specifically required by applicable Canadian securities law, the Corporation undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. These forward-looking statements should not be relied upon as representing the Corporation’s views as of any date subsequent to the date of this press release. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

EN
28/06/2019

Reports on Acasta Enterprises Incorporated

 PRESS RELEASE

Apollo Healthcare Corp. Reports First Quarter of 2021 Results

TORONTO--(BUSINESS WIRE)-- Apollo Healthcare Corp. (formerly Acasta Enterprises Inc.) (TSX: AHC, OTC QX: AHCCF) (“Apollo” or the “Company”) today announced financial results for the first quarter ended March 31, 2021. The Company’s un-audited interim financial statements for the three months ended March 31, 2021, as well as its accompanying management discussion and analysis (MD&A) have been filed on SEDAR. Copies of the filings may be obtained at . All values in this news release and the Company’s financial disclosures are in Canadian dollars unless otherwise stated. Highlights Revenues f...

 PRESS RELEASE

Apollo Healthcare Corp. Reports Fourth Quarter of 2020 Results

TORONTO--(BUSINESS WIRE)-- Apollo Healthcare Corp. (formerly Acasta Enterprises Inc.) (TSX: AHC, OTC QX: AHCCF) (“Apollo” or the “Company”) today announced financial results for the quarter and year ended December 31, 2020. The Company’s audited consolidated financial statements for the three months and year ended December 31, 2020, as well as its accompanying management discussion and analysis (MD&A) have been filed on SEDAR. Copies of the filings may be obtained at . All values in this news release and the Company’s financial disclosures are in Canadian dollars unless otherwise stated. Fin...

 PRESS RELEASE

Apollo Healthcare Corp. Commences Process to Join OTC QX Marketplace i...

TORONTO--(BUSINESS WIRE)-- Apollo Healthcare Corp (TSX: AHC) (“Apollo” or the “Company”) is pleased to announce that it will be joining the OTC QX marketplace in the United States. Joining the OTC QX will facilitate trading in Apollo’s securities by U.S. investors. The Company expects to complete the process before the end of its first quarter of 2021 and will update the market once the process is complete. Apollo will maintain its primary listing on the Toronto Stock Exchange. Apollo is also pleased to announce that it has retained the services of Hybrid Financial to heighten market and bran...

 PRESS RELEASE

Apollo Healthcare Corp. Reports Third Quarter of 2020 Results

TORONTO--(BUSINESS WIRE)-- Apollo Healthcare Corp. (formerly Acasta Enterprises Inc.) (TSX: AHC) (“Apollo” or the “Company”) today announced financial results for the quarter ended September 30, 2020. The Company’s unaudited interim condensed consolidated financial statements for the three and nine months ended September 30, 2020, as well as its accompanying management discussion and analysis (MD&A) have been filed on SEDAR. Copies of the filings may be obtained at . All values in this news release and the Company’s financial disclosures are in Canadian dollars unless otherwise stated. Finan...

 PRESS RELEASE

Apollo Healthcare Corp. Announces Board of Directors Changes

TORONTO--(BUSINESS WIRE)-- Apollo Healthcare Corp. (TSX: AHC) (“Apollo” or the “Company”) announces that Stan Bharti has stepped down as a director of the Company. Charles Wachsberg has agreed to assume Mr. Bharti’s role as Chair of the Board. “We truly value Mr Bharti’s support and his numerous contributions to our Board as Chair. Mr. Bharti has played a key role in the successful turnaround of our business and we are most appreciative and grateful for his efforts” said Charles Wachsberg. In addition, the Company is pleased to announce the appointment of Andrew Schachter to Apollo’s Board...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch